LifeTech Scientific Corporation Stock
Equities
1302
KYG548721177
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.62 HKD | 0.00% | -4.14% | -31.06% |
Sales 2024 * | 1.47B 203M 1.59B | Sales 2025 * | 1.77B 245M 1.91B | Capitalization | 6.96B 960M 7.5B |
---|---|---|---|---|---|
Net income 2024 * | 328M 45.26M 354M | Net income 2025 * | 399M 55.05M 430M | EV / Sales 2024 * | 4.72 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 3.92 x |
P/E ratio 2024 * |
21.5
x | P/E ratio 2025 * |
16.7
x | Employees | 1,448 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 83.41% |
1 week | -4.14% | ||
Current month | -4.14% | ||
1 month | -7.95% | ||
3 months | -14.74% | ||
6 months | -28.32% | ||
Current year | -31.06% |
Managers | Title | Age | Since |
---|---|---|---|
Yue Hui Xie
CEO | Chief Executive Officer | 54 | 06-08-16 |
Jian Xiong Liu
DFI | Director of Finance/CFO | 53 | 10-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jian Xiong Liu
DFI | Director of Finance/CFO | 53 | 10-08-31 |
Feng Jiang
BRD | Director/Board Member | 61 | 14-03-31 |
Yue Hui Xie
CEO | Chief Executive Officer | 54 | 06-08-16 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.16% | 2 M€ | -14.14% | ||
0.02% | 114 M€ | +4.02% | - | |
0.02% | 4 M€ | -4.41% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 1.62 | 0.00% | 3,342,000 |
24-06-06 | 1.62 | 0.00% | 3,854,000 |
24-06-05 | 1.62 | -2.99% | 2,646,000 |
24-06-04 | 1.67 | +0.60% | 4,456,000 |
24-06-03 | 1.66 | -1.78% | 18,366,000 |
Delayed Quote Hong Kong S.E., June 07, 2024 at 04:09 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-31.06% | 960M | |
+8.93% | 222B | |
+13.67% | 195B | |
+23.40% | 148B | |
+33.07% | 113B | |
+4.18% | 66.45B | |
+12.79% | 53.11B | |
+3.16% | 50.03B | |
-4.55% | 38.8B | |
-2.63% | 34.85B |
- Stock Market
- Equities
- 1302 Stock